HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wei, C.-H. Articles by Levitsky, V. Search for Related Content PubMed PubMed Citation Articles by Wei, C.-H. Articles by Levitsky, V.

A Partially Agonistic Peptide Acts as a Selective Inducer of Apoptosis in CD8⁺ CTLs¹

Cheng-Hong Wei^*, Craig Beeson, Maria G. Masucci^* and Victor Levitsky^2,*

^* Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden; and University of Washington, Department of Chemistry, Seattle, WA 98195

We have analyzed the effect of partially agonistic peptides on the activation and survival of CTL clones specific for a highly immunogenic HLA A11-restricted peptide epitope derived from the EBV nuclear Ag-4. Several analogues with substitutions of TCR contact residues were able to trigger cytotoxic activity without induction of IL-2 mRNA and protein or T cell proliferation. Triggering with these partial agonists in the absence of exogenous IL-2 resulted in down-regulation of the cytotoxic potential of the specific CTLs. One analogue selectively triggered apoptosis as efficiently as the original epitope, subdividing the partial agonists into apoptosis-inducing and noninducing ligands. Analysis of early T cell activation events, induction of Ca²⁺ influx, and acid release did not reveal significant differences between the two types of analogue peptides. These results demonstrate that some partial agonists can dissociate the induction of CTL death from CTL activation. Peptides with such properties may serve as useful tools to study signal transduction pathways in CD8⁺ lymphocytes and as therapeutic agents modulating natural immune responses.

This article has been cited by other articles:

				K. Fischer, S. Voelkl, J. Berger, R. Andreesen, T. Pomorski, and A. Mackensen Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells Blood, December 15, 2006; 108(13): 4094 - 4101. [Abstract] [Full Text] [PDF]

				M. Uhlin, M. G. Masucci, and V. Levitsky Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes PNAS, June 28, 2005; 102(26): 9264 - 9269. [Abstract] [Full Text] [PDF]

				E. Sandalova, C.-H. Wei, M. G. Masucci, and V. Levitsky Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering PNAS, March 2, 2004; 101(9): 3011 - 3016. [Abstract] [Full Text] [PDF]

				E. Teixeiro, P. Fuentes, B. Galocha, B. Alarcon, and R. Bragado T Cell Receptor-mediated Signal Transduction Controlled by the beta Chain Transmembrane Domain. APOPTOSIS-DEFICIENT CELLS DISPLAY UNBALANCED MITOGEN-ACTIVATED PROTEIN KINASES ACTIVITIES UPON T CELL RECEPTOR ENGAGEMENT J. Biol. Chem., February 1, 2002; 277(6): 3993 - 4002. [Abstract] [Full Text] [PDF]

				C.-H. Wei, H. Yagita, M. G. Masucci, and V. Levitsky Different Programs of Activation-Induced Cell Death Are Triggered in Mature Activated CTL by Immunogenic and Partially Agonistic Peptide Ligands J. Immunol., January 15, 2001; 166(2): 989 - 995. [Abstract] [Full Text] [PDF]